Anna R Michmerhuizen

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Endoplasmic Reticulum

Estrogen Receptor

Top Venues

NPJ breast cancer

British journal of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Anna R Michmerhuizen, Lynn M Lerner, Connor Ward, Andrea M Pesch, Amanda Zhang, Rachel Schwartz, Kari Wilder-Romans, Joel R Eisner, James M Rae, Lori J Pierce, Corey W Speers
Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer. British journal of cancer 127 (5) (2022)
Anna R Michmerhuizen, Lynn M Lerner, Andrea M Pesch, Connor Ward, Rachel Schwartz, Kari Wilder-Romans, Meilan Liu, Charles Nino, Kassidy M Jungles, Ruth D Azaria, Alexa Jelley, Nicole Zambrana Garcia, Alexis Harold, Amanda Zhang, Bryan Wharram, Daniel F Hayes, James M Rae, Lori J Pierce, Corey W Speers
Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models. NPJ breast cancer 8 (1) (2022)
Anna R Michmerhuizen, Lynn M Lerner, Andrea M Pesch, Connor Ward, Rachel Schwartz, Kari Wilder-Romans, Meilan Liu, Charles Nino, Kassidy M Jungles, Ruth D Azaria, Alexa Jelley, Nicole Zambrana Garcia, Alexis Harold, Amanda Zhang, Bryan Wharram, Daniel F Hayes, James M Rae, Lori J Pierce, Corey W Speers
Publisher Correction: Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models. NPJ breast cancer 8 (1) (2022)
Anna R Michmerhuizen, Daniel E Spratt, Lori J Pierce, Corey W Speers
ARe we there yet? Understanding androgen receptor signaling in breast cancer. NPJ breast cancer 6 (2020)
Andrea M Pesch, Nicole H Hirsh, Benjamin C Chandler, Anna R Michmerhuizen, Cassandra L Ritter, Marlie P Androsiglio, Kari Wilder-Romans, Meilan Liu, Christina L Gersch, José M Larios, Lori J Pierce, James M Rae, Corey W Speers
Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor-Positive Breast Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (24) (2020)